Abbott Laboratories Profit Margin 2006-2018 | ABT

Current and historical gross margin, operating margin and net profit margin for Abbott Laboratories (ABT) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Abbott Laboratories net profit margin as of June 30, 2018 is 3.13%.
Abbott Laboratories Annual Profit Margins
Abbott Laboratories Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $124.469B $27.390B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $130.392B 19.99
Stryker (SYK) United States $65.486B 25.30
Boston Scientific (BSX) United States $52.703B 27.42
Baxter (BAX) United States $38.339B 26.09
Zimmer Biomet Holdings (ZBH) United States $25.981B 16.69
ResMed (RMD) United States $15.127B 30.03
Smith & Nephew SNATS (SNN) United Kingdom $15.102B 0.00
Canopy Growth (CGC) Canada $12.198B 0.00
Perrigo (PRGO) Ireland $9.955B 14.13
Bio-Rad Laboratories (BIO) United States $8.631B 55.42
Hill-Rom Holdings (HRC) United States $5.963B 20.23
Haemonetics (HAE) United States $5.755B 52.52
ICU Medical (ICUI) United States $5.615B 38.05
Insulet (PODD) United States $5.470B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.448B 0.00
Agios Pharmaceuticals (AGIO) United States $4.104B 0.00
Hutchison China MediTech (HCM) China $3.991B 0.00
NuVasive (NUVA) United States $3.474B 32.96
Neogen (NEOG) United States $3.463B 52.44
National Vision Holdings (EYE) United States $3.208B 70.83
Quidel (QDEL) United States $2.646B 54.22
NxStage Medical (NXTM) United States $1.849B 0.00
Phibro Animal Health (PAHC) United States $1.762B 25.09
Cardiovascular Systems (CSII) United States $1.286B 740.80
AtriCure (ATRC) United States $1.116B 0.00
VAREX IMAGING (VREX) United States $1.004B 16.40
Owens & Minor (OMI) United States $0.975B 10.43
Eagle Pharmaceuticals (EGRX) United States $0.933B 27.55
Cerus (CERS) United States $0.921B 0.00
PetIQ (PETQ) United States $0.915B 29.94
OraSure Technologies (OSUR) United States $0.894B 58.48
Surmodics (SRDX) United States $0.877B 105.90
MacroGenics (MGNX) United States $0.823B 0.00
Omeros (OMER) United States $0.746B 0.00
Insys Therapeutics (INSY) United States $0.692B 0.00
Meridian Bioscience (VIVO) United States $0.657B 22.46
LeMaitre Vascular (LMAT) United States $0.556B 27.69
Lantheus Holdings (LNTH) United States $0.532B 16.52
NanoString Technologies (NSTG) United States $0.482B 0.00
TG Therapeutics (TGTX) United States $0.477B 0.00
Quanterix (QTRX) United States $0.398B 0.00
Evolus (EOLS) United States $0.374B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.356B 0.00
Cytosorbents (CTSO) United States $0.342B 0.00
Utah Medical Products (UTMD) United States $0.332B 21.38
Surface Oncology (SURF) United States $0.232B 0.00
Rockwell Medical (RMTI) United States $0.218B 0.00
BioLife Solutions (BLFS) United States $0.217B 0.00
Bovie Medical (BVX) United States $0.192B 0.00
Chimerix (CMRX) United States $0.179B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.157B 0.00
Fonar (FONR) United States $0.150B 7.42
Chembio Diagnostics (CEMI) United States $0.140B 0.00
Female Health (VERU) United States $0.080B 0.00
United-Guardian (UG) United States $0.080B 17.51
Trinity Biotech (TRIB) Ireland $0.075B 22.50
Oramed Pharmaceuticals (ORMP) Israel $0.075B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.073B 0.00
InfuSystems Holdings (INFU) United States $0.064B 0.00
CAS Medical Systems (CASM) United States $0.058B 0.00
Neurotrope (NTRP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.047B 0.00
Akers Biosciences Inc (AKER) United States $0.033B 0.00
Valeritas Holdings (VLRX) United States $0.032B 0.00
Capricor Therapeutics (CAPR) United States $0.028B 0.00
Myomo (MYO) United States $0.023B 0.00
Senestech (SNES) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.016B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.010B 0.00